Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 246,077,536
  • Shares Outstanding, K 5,606,688
  • Annual Sales, $ 41,908 M
  • Annual Income, $ 9,616 M
  • 60-Month Beta 0.74
  • Price/Sales 5.95
  • Price/Cash Flow 15.06
  • Price/Book 3.73
Trade PFE with:

Options Overview

Details
  • Implied Volatility 24.87%
  • Historical Volatility 19.69%
  • IV Percentile 57%
  • IV Rank 18.69%
  • IV High 60.64% on 12/09/20
  • IV Low 16.65% on 06/11/21
  • Put/Call Vol Ratio 0.87
  • Today's Volume 266,951
  • Volume Avg (30-Day) 285,309
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 2,838,291
  • Open Int (30-Day) 2,656,634

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.07
  • Number of Estimates 5
  • High Estimate 1.22
  • Low Estimate 0.96
  • Prior Year 0.72
  • Growth Rate Est. (year over year) +48.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.31 +1.34%
on 09/17/21
51.86 -15.37%
on 08/18/21
-6.53 (-12.95%)
since 08/17/21
3-Month
38.70 +13.41%
on 06/18/21
51.86 -15.37%
on 08/18/21
+4.41 (+11.17%)
since 06/17/21
52-Week
33.36 +31.56%
on 02/26/21
51.86 -15.37%
on 08/18/21
+7.07 (+19.20%)
since 09/17/20

Most Recent Stories

More News
The Latest: American Samoa reports first case of coronavirus

PAGO PAGO, AMERICAN SAMOA -- American Samoa reported its first case of coronavirus on Friday.

PFE : 43.89 (-1.30%)
US panel backs COVID-19 boosters only for seniors, high-risk

WASHINGTON (AP) — Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed...

PFE : 43.89 (-1.30%)
JNJ : 164.75 (-0.28%)
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY(R) Booster for Emergency Use in People 65 and Older and Certain High-risk Populations

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously...

PFE : 43.89 (-1.30%)
BNTX : 359.18 (-3.61%)
Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study

and , /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: , Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) announced today ahead of the European Society for Medical Oncology (ESMO) Congress...

ALPMY : 17.0800 (-0.81%)
PFE : 43.89 (-1.30%)
SEC charges Florida man for insider trading of Mylan stock

NEW YORK (AP) — A former executive at pharmaceutical company Mylan has pleaded guilty to insider trading in the company’s securities, the Justice Department said Friday.

$SPX : 4,432.99 (-0.91%)
$DOWI : 34,584.88 (-0.48%)
$IUXX : 15,333.47 (-1.18%)
PFE : 43.89 (-1.30%)
FDA advisory panel soundly rejects a plan to offer Pfizer booster shots against COVID-19 to most Americans

WASHINGTON (AP) — FDA advisory panel soundly rejects a plan to offer Pfizer booster shots against COVID-19 to most Americans.

PFE : 43.89 (-1.30%)
Turner Syndrome Market: by Industry Type, Growth, Share, Size, Key Manufacturers, Revenue, Trends, Growth, Geographical Outlook and Forecast to 2028

Research Nester published a report titled ": Global Demand Analysis & Opportunity Outlook 2028"which delivers a detailed overview of the turner syndrome drug market in terms of market segmentation by type,...

PFE : 43.89 (-1.30%)
NOVN : 8.56 (+1.30%)
BHC : 27.27 (-1.02%)
JNJ : 164.75 (-0.28%)
LLY : 230.10 (-0.41%)
ABT : 126.79 (-0.51%)
MRK : 71.68 (-0.40%)
SAN : 3.58 (-3.24%)
GSK.LN : 1,388.200 (-0.49%)
Axsome (AXSM) Begins Late-Stage Sleep Disorder Study on AXS-12

Axsome (AXSM) is developing AXS-12 as a potential treatment for narcolepsy. The company initiates enrollment in a phase III study evaluating AXS-12.

PFE : 43.89 (-1.30%)
JAZZ : 133.22 (+1.12%)
AXSM : 29.72 (+4.17%)
HRMY : 36.79 (-0.84%)
AbbVie (ABBV) Files for Rinvoq in Ulcerative Colitis in US & EU

AbbVie (ABBV) files regulatory applications to the FDA and the EMA, seeking approval for a new indication of Rinvoq - active ulcerative colitis.

PFE : 43.89 (-1.30%)
LLY : 230.10 (-0.41%)
INCY : 75.99 (+1.27%)
ABBV : 107.73 (-0.32%)
Fed reviews ethics policies after prolific trading uncovered

WASHINGTON (AP) — The Federal Reserve is reviewing the ethics policies that govern the financial holdings and activities of its senior officials in the wake of recent disclosures that two regional Fed...

$SPX : 4,432.99 (-0.91%)
$DOWI : 34,584.88 (-0.48%)
$IUXX : 15,333.47 (-1.18%)
FNMA : 0.9450 (-0.78%)
JNJ : 164.75 (-0.28%)
PFE : 43.89 (-1.30%)
PSX : 66.02 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

3rd Resistance Point 45.61
2nd Resistance Point 45.04
1st Resistance Point 44.46
Last Price 43.89
1st Support Level 43.31
2nd Support Level 42.74
3rd Support Level 42.16

See More

52-Week High 51.86
Fibonacci 61.8% 44.79
Last Price 43.89
Fibonacci 50% 42.61
Fibonacci 38.2% 40.43
52-Week Low 33.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar